Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Argonaute 1 (AGO1) is a highly conserved RNA-binding protein and core component of the RNA-induced silencing complex (RISC), which mediates gene silencing by microRNAs (miRNAs) and, in some organisms, small interfering RNAs (siRNAs). AGO1 binds to single-stranded guide RNAs and associates with complementary sequences on target mRNAs, resulting in translational repression, mRNA deadenylation, and decay. While the best-studied endonuclease (slicing) catalytic activity among Argonaute proteins belongs to AGO2 in mammals, AGO1 functions primarily in miRNA-mediated translational inhibition. In Drosophila and plants, AGO1 is essential for normal development and cell growth regulation and may have additional roles in direct transcriptional control, such as repressing the Myc gene. Mutations in AGO1 lead to severe developmental defects, highlighting its critical function in post-transcriptional regulation. Argonaute proteins do not act as classic therapeutic targets or receptors but constitute an essential part of the RNA interference machinery fundamental to eukaryotic gene expression control.
Not directly targeted by drugs; molecular mechanisms include: - Formation of RISC with miRNA for translational repression or mRNA decay - Sequence-specific binding to target mRNAs via small RNA guides - In some contexts (e.g. mammals: AGO2), endonuclease ("slicer") activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argonaute 1 (AGO1).